1-20 of 22
Nancy L. Bartlett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma

Open Access
Clinical Trials & Observations
Swaminathan P. Iyer, Neha Mehta-Shah, Ranjana H Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo-Domenech, Giuseppe Rossi, Won Seog Seog Kim, Onder Alpdogan, Tatyana A. Feldman, Vincent Camus, Giuseppe Gritti, Pier Luigi Zinzani, David Belada, Jiri Mayer, Ilseung Choi, June-Won Cheong, Evelyn Rustia, Keenan Fenton, Michelle Fanale, Kerry J. Savage, Steven M Horwitz
Journal: Blood Advances
Blood Adv bloodadvances.2024015282.
https://doi.org/10.1182/bloodadvances.2024015282
Published: 2025
Includes: Supplemental data
Journal Articles

Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

Open Access
Clinical Trials & Observations
Alex F. Herrera, Stephen M. Ansell, Pier Luigi Zinzani, John Radford, Kami J Maddocks, Antonio Pinto, Graham P. Collins, Veronika Bachanova, Nancy L. Bartlett, Isabelle Bence-Bruckler, Mehdi Hamadani, Justin Kline, Jiri Mayer, Kerry J. Savage, Ranjana H Advani, Paolo F. Caimi, Olivier Casasnovas, Tatyana A. Feldman, Brian T Hess, Mariana Bastos-Oreiro, Sunil Iyengar, Árpád Szomor, William Townsend, Marc André, Jerzy Dyczkowski, Karin Havenith, Marie Toukam, Serafino Pantano, Hans G. Cruz, Luqiang Wang, Yanina Negievich, Melanie Lucero, Jens U. Wuerthner, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv bloodadvances.2024015600.
https://doi.org/10.1182/bloodadvances.2024015600
Published: 2025
Includes: Supplemental data
Journal Articles

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results

Open Access
Clinical Trials & Observations
Bruce D. Cheson, Nancy L. Bartlett, Betsy Knopf, Hun J. Lee, Ranjana H. Advani, Beth Christian, Catherine S. Diefenbach, Tatyana A. Feldman, Stephen M. Ansell
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3750–3753.
https://doi.org/10.1182/bloodadvances.2025016470
Published: 2025
Journal Articles

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022

Open Access
Clinical Trials & Observations
Ajay K. Gopal, Philippe Armand, Sattva S. Neelapu, Nancy L. Bartlett, Stephen E. Spurgeon, John Kuruvilla, Kerry J. Savage, John P. Leonard, Arnold B. Gelb, Nasir Ahmed, Shiqi Dong, Sai Praneeth Bathena, Rasika Suryawanshi, Jenny Qun Wu, Sheen Wang, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3383–3394.
https://doi.org/10.1182/bloodadvances.2024015086
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Open Access
Clinical Trials & Observations
Elise A. Chong, Elicia Penuel, Ellen B. Napier, Rachel K. Lundberg, Lihua E. Budde, Mazyar Shadman, Matthew J. Matasar, Nancy L. Bartlett, Ian W. Flinn, Francesc Bosch, Keith Fay, Andre Goy, Anita Kumar, Loretta J. Nastoupil, Michael C. Wei, Mei Wu, Shen Yin, Joseph A. Fraietta, Emeline R. Chong, Stephen J. Schuster
Journal: Blood Advances
Blood Adv (2025) 9 (4): 696–703.
https://doi.org/10.1182/bloodadvances.2024013640
Published: 2025
Includes: Supplemental data
Journal Articles

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

Free
Clinical Trials & Observations
Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana Advani, Mark Roschewski
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5855–5863.
https://doi.org/10.1182/bloodadvances.2024013277
Published: 2024
Includes: Supplemental data
Journal Articles

Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Free
Clinical Trials & Observations
Cody A. Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A. Russler-Germain, Felix Frenkel, Erica K. Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L. Skidmore, Marcus P. Watkins, Thomas B. Mooney, Jason R. Walker, Kilannin Krysiak, Felicia Gomez, Catrina C. Fronick, Robert S. Fulton, Robert D. Schreiber, Neha Mehta-Shah, Amanda F. Cashen, Brad S. Kahl, Ravshan Ataullakhanov, Nancy L. Bartlett, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4035–4049.
https://doi.org/10.1182/bloodadvances.2022007792
Published: 2024
Includes: Supplemental data
Journal Articles

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

Free
Clinical Trials & Observations
Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina Wagner-Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3189–3199.
https://doi.org/10.1182/bloodadvances.2023011657
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Free
Clinical Trials & Observations
Sarah C. Rutherford, Jun Yin, Levi D. Pederson, Kristie A. Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D. Cheson, Nancy L. Bartlett, Sumithra J. Mandrekar, John P. Leonard
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1464–1468.
https://doi.org/10.1182/bloodadvances.2023012090
Published: 2024
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Armin Ghobadi, Nicole C. Foley, Jared Cohen, Michael P. Rettig, Amanda F. Cashen, Leah Gehrs, Stephanie Christ, Emily Street, Nicholas Wallace, Julie Ritchey, Neha Mehta-Shah, Peter Westervelt, Todd A. Fehniger, Brad Kahl, Nancy L. Bartlett, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (3): 513–522.
https://doi.org/10.1182/bloodadvances.2023011130
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis

Free
Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P. Watkins, Montreh Tavakkoli, Celeste Bello, Pallawi Torka, Nishitha Reddy, Colin Thomas, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Geoffrey Shouse, Adam J. Olszewski, Nancy L. Bartlett
Journal: Blood Advances
Blood Adv (2024) 8 (3): 549–552.
https://doi.org/10.1182/bloodadvances.2023011698
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Free
Clinical Trials & Observations
Kaitlin Annunzio, Natalie S. Grover, Rina Li Welkie, Pallawi Torka, Marcus P. Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S. Oh, Heather Reves, Daniel Jones, Walter Hanel, Beth Christian, Praveen Ramakrishnan Geethakumari, Reem Karmali, Stefan K. Barta, Nancy L. Bartlett, Adam J. Olszewski, Narendranath Epperla
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6839–6843.
https://doi.org/10.1182/bloodadvances.2023011288
Published: 2023
Includes: Supplemental data
Journal Articles

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

Free
David A. Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F. Cashen, Neha Mehta-Shah, Brad S. Kahl, Nancy L. Bartlett, Juan P. Alderuccio, Izidore S. Lossos, Sarah L. Ondrejka, Eric D. Hsi, Peter Martin, John P. Leonard, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5524–5539.
https://doi.org/10.1182/bloodadvances.2023010779
Published: 2023
Includes: Supplemental data
Journal Articles

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Free
Clinical Trials & Observations
Rahul Lakhotia, Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Ariela Noy, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5320–5324.
https://doi.org/10.1182/bloodadvances.2023010223
Published: 2023
Journal Articles

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

Free
Clinical Trials & Observations
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea, Timothy S. Oh, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Irl Brian Greenwell, Emily Hansinger, Elvira Umyarova, Kaitlin Annunzio, Yazeed Sawalha, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Natalie S. Grover, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5038–5046.
https://doi.org/10.1182/bloodadvances.2023010133
Published: 2023
Includes: Supplemental data
Journal Articles

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Nancy L. Bartlett, Sarit Assouline, Pratyush Giri, Stephen J. Schuster, Chan Y. Cheah, Matthew Matasar, Gareth P. Gregory, Dok Hyun Yoon, Mazyar Shadman, Keith Fay, Sung-Soo Yoon, Carlos Panizo, Ian Flinn, Anna Johnston, Francesc Bosch, Laurie H. Sehn, Michael C. Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, Lihua E. Budde
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4926–4935.
https://doi.org/10.1182/bloodadvances.2022009260
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Free
Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Free
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Free
Clinical Trials & Observations
R. Andrew Harkins, Sharvil P. Patel, Michelle J. Lee, Jeffrey M. Switchenko, Stephen M. Ansell, Nancy L. Bartlett, Kristie A. Blum, Amanda F. Cashen, Carla Casulo, Jonathan W. Friedberg, Patrick B. Johnston, Brad S. Kahl, John P. Leonard, Brian K. Link, Izidore S. Lossos, Peter Martin, Matt J. Maurer, Neha Mehta-Shah, Patrick M. Reagan, Jason R. Westin, Jean L. Koff, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2745–2756.
https://doi.org/10.1182/bloodadvances.2021006504
Published: 2022
Includes: Supplemental data
Journal Articles

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma

Free
Clinical Trials & Observations
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, Patrick M. Reagan, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, Michael Crump, John Kuruvilla, Eric Van Den Neste, Umar Farooq, Lynn Navale, Venita DePuy, Jenny J. Kim, Christian Gisselbrecht
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4149–4155.
https://doi.org/10.1182/bloodadvances.2020003848
Published: 2021
Includes: Supplemental data